Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
arch venture partners
artificial intelligence
bill martin
bio
biotech ipos
boston
boston blog main
boston top stories
clinical trials
drug development
dyne therapeutics
executive
fda
funding
gv
health
johnson & johnson
julie sunderland
life sciences
machine learning
managing partner
metacrine
myotonic dystrophy type 1
national blog main
neuroscience
nonalcoholic steatohepatitis
polaris partners
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
science
startups
ulcerative colitis
What
company
disorders
2
×
million
therapeutics
approach
betting
blackthorn
brings
challenges
create
developing
drug
drugs
dyne
dyne’s
effective
finding
genetic
gv
health
ipo
learning
machine
medicine
medicines
mental
muscle
muscular
neurobehavioral
numerous
personalized
preclinical
pulls
raised
rare
stage
technological
topped
treat
treatments
Language
unset
Current search:
disorders
×
biotech
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
